Vivatis Pharma

What Vivatis Pharma does

VIVATIS Pharma GmbH is a privately held Hamburg-based B2B distributor and service provider for the pharmaceutical and nutraceutical industries, founded around 2000 and operating across 25+ years. The company sources and distributes active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and a broad portfolio of nutraceutical ingredients, serving pharmaceutical manufacturers, marketing authorization holders, generic drug producers, nutraceutical brands, cosmetics manufacturers, functional food producers, and sports nutrition brands. Its business model combines ingredient trading on a transaction-fee basis with custom formulation services (full-service from formula selection through manufacturing, labeling, packaging, and logistics) and licensing of three patented proprietary ingredients: GreenIuronic® (vegan hyaluronic acid from Tremella fuciformis), GreenDroitin® (vegan chondroitin sulfate), and VivaBiome™ (Konjac Glucomannan-based prebiotic blend).

The company operates through wholly-owned regional offices in Germany, Spain, Italy, France, Benelux, and Poland, with direct distribution into Czech Republic, Slovakia, and the Baltic states, supplemented by channel partners Alifarma (Iberia) and Faravelli (Italy). It holds a premium partner network of 40+ international ingredient suppliers including Activ Inside, KSM-66, OmniActive, and Taiyo, and maintains a regulatory stack including ISO 9001, HACCP (since 2009), EU GMP compliance, EUDRA and EMA SPOR/OMS registration, German Medicinal Products Act §72(1) import authorization, ABCERT organic certification (since 2013), and Kosher certification. Customer acquisition combines direct enterprise field sales, channel distribution, and event-driven marketing at major European nutraceutical trade shows (Vitafoods Europe, Nutraceuticals, NutraFood Poland, In-Vitality Milan), supported by content marketing, a podcast ('Besser mit Stoff'), and active LinkedIn/Instagram presence.

At the holding-company level, Vivatis Holding divested Senna (Austrian producer of margarine, sauces, and dressings, €80m 2025 sales) to Orkla Food Ingredients in 2026, sharpening the group's focus on pharmaceutical and nutraceutical core operations. The company is led by four Managing Directors (Peter Franck, Peter Bos, Fedor Dreher for API, Dennis Lange for Nutraceuticals) and is not publicly listed.

Name

Vivatis Pharma

Legal name

VIVATIS Pharma GmbH

Website

https://vivatis.de

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

VIVATIS Pharma is a privately held Hamburg-based B2B distributor of pharmaceutical active ingredients, intermediates, and patented nutraceutical ingredients (GreenIuronic®, GreenDroitin®, VivaBiome™), serving pharma manufacturers, nutraceutical brands, cosmetics, and functional food producers across 11 European country markets via regional offices and distribution partners.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Nutraceutical Ingredient Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYHLAIAJAO

Compounding Ingredient & API Distributors (Pharma Supply)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYCRADAGAD

Herbal & Botanical Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAE

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAF

Probiotics & Digestive Health Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAM

Healthy Aging & Cognitive Support Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAI

Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

Keywords

• Pharmaceutical ingredients distribution
• Nutraceutical raw materials
• Active pharmaceutical ingredients
• Vegan hyaluronic acid
• Formulation concept services

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Raw Materials Trading: Trading of pharmaceutical active ingredients (APIs), intermediates, and excipients to pharmaceutical manufacturers and marketing authorization holders
2. Nutraceutical Ingredients Distribution: Distribution of nutraceutical ingredients to manufacturers of dietary supplements and functional foods
3. Finished Formulation Services: Custom concept solutions and full-service manufacturing of premade nutraceutical products including labeling and packaging under European pharmaceutical regulations
4. Proprietary Branded Ingredients: Exclusive proprietary ingredients (GreenIuronic®, GreenDroitin®, VivaBiome™) with differentiation value for customers seeking market differentiation

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

VIVATIS Pharma is an independent B2B full-service provider distributing pharmaceutical active ingredients (APIs), intermediates, and nutraceutical raw materials to manufacturers, marketing authorization holders, distributors, and brand owners. The company also distributes proprietary patented vegan ingredients (GreenIuronic®, GreenDroitin®, VivaBiome™) and offers custom formulation concept services including ingredient sourcing, manufacturing, labeling, packaging, and logistics under European pharmaceutical regulations.

Product overview

VIVATIS Pharma is a B2B service company and independent partner for raw materials in the pharmaceutical and nutraceutical sectors. The company operates with three core product categories: Active Pharmaceutical Ingredients (APIs) and Intermediates for the pharma industry, and Nutraceuticals including proprietary branded ingredients (GreenIuronic®, GreenDroitin®, VivaBiome™) plus formulation concepts for finished products. They offer comprehensive services from ingredient sourcing through manufacturing, packaging, and logistics across multiple European markets (Germany, Spain, Italy, France, Benelux, Poland, Baltic states) through regional offices. The company's motto is 'From molecule to finished product' (Vom Molekül zum fertigen Produkt).

Differentiator

Problem solved

Functional benefit

Brands

• GreenIuronic®: The world's first patented vegetable hyaluronic acid derived from Tremella fuciformis fungus. Offers superior hydration and joint support. Available in certified Organic grade.
• GreenDroitin®
• VivaBiome™

Products and services

• GreenIuronic® World's first patented vegetable hyaluronic acid derived from Tremella fuciformis fungus, offering superior bioabsorption and enhanced efficacy compared to traditional sodium hyaluronate. Suitable for skin hydration and joint health applications. Available in standard and certified Organic grades. Composition: >80% vegan hyaluronic acid, molecular weight 1,500-4,000 kDa. Dosage: 200mg/day for joint health, 100mg/day for skin benefits. Distributed to nutraceutical and cosmetic manufacturers.
• GreenDroitin® First and only vegan chondroitin sulfate sourced from Tremella fuciformis fungus, offering high bioavailability and digestive comfort without animal-derived ingredients. Effective at one-third the typical dose compared to conventional chondroitin sources. 200mg daily dose. Distributed to nutraceutical manufacturers for joint health formulations.
• VivaBiome™ Patented prebiotic fiber blend with Konjac Glucomannan (KGM) and its hydrolyzed form (KOG) for metabolic health support. Promotes gut balance by boosting beneficial bacteria (Lactobacillus and Bifidobacterium) while suppressing pathogens. Supports glucose control, cholesterol reduction, and healthy weight management. Distributed to nutraceutical and functional food manufacturers.
• Active Pharmaceutical Ingredients (APIs) Pharmaceutical raw materials including generic APIs and product synthesis services. VIVATIS serves as an independent partner for pharmaceutical manufacturers, marketing authorization holders, traders, and brand owners. Supported by EU GMP compliance, EMA SPOR/OMS registration (ORG-100020175), and import authorization per section 72(1) of the German Medicinal Products Act.
• Intermediates Pharmaceutical intermediate compounds for the pharmaceutical industry supply chain, distributed to pharmaceutical manufacturers and marketing authorization holders.
• Nutraceutical Ingredients Nutraceutical ingredients and high-quality functional ingredients portfolio for manufacturers and brands in the nutraceuticals sector. Includes proprietary branded ingredients (GreenIuronic®, GreenDroitin®, VivaBiome™) sourced through a premium partner network of international suppliers.
• Finished Formulations / Formulation Concepts Custom concept solutions for premade nutraceutical products. Full-service offering including formula selection, ingredient sourcing, manufacturing oversight, labeling, packaging, storage, and logistics in accordance with European pharmaceutical regulations. Targeted at nutraceutical brands seeking turnkey product development.
• Packaging Services Packaging services for pharmaceutical and nutraceutical products, provided as part of the full-service supply chain offering to manufacturers and brand owners.

Quantifiable outcome

• GreenIuronic® improves collagen absorption across intestinal barrier by up to 80%
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• NuritascoreChannel Partner/ Reseller/ Distributor · 24 April 2026VIVATIS Pharma serves as authorized distributor for Nuritas PeptiStrong® ingredient in Poland, Czech Republic, Slovakia, and the three Baltic markets (Estonia, Latvia, Lithuania). PeptiStrong is a clinically validated plant-based peptide ingredient for healthy aging.
• AlifarmacoreChannel Partner/ Reseller/ Distributor · 24 April 2026Alifarma serves as regional distribution partner for Nuritas products in Spain and Portugal markets.
• FaravellicoreChannel Partner/ Reseller/ Distributor · 24 April 2026Faravelli serves as regional distribution partner for Nuritas products in Italy.
• Orkla Food Ingredients (OFI)minorOthers · 18 February 2026VIVATIS Holding divested Senna (Austrian producer of margarine, sauces, and dressings) to Orkla Food Ingredients. Deal expected to close H1 2026 pending regulatory approval. Senna operates in 20+ countries with €80m sales in 2025.
• Premium Ingredient Partners NetworkcoreStrategic or Co-development PartnerVIVATIS works with top-tier international partners including Activ Inside, Amicogen, KSM-66, OmniActive, Taiyo, Gronvedt, Bioenergy Life Science, BioNeopara, and 40+ other suppliers. Partners selected according to strict quality and production standards with comprehensive due diligence process for documentation, compliance, and traceability.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Barentz International: European-based specialty distributor of nutraceutical, pharmaceutical, and personal care ingredients with a multi-country sales network — directly comparable to Vivatis in target customers and product categories.
• IMCD Group: Global specialty distribution company focused on food, nutrition, and pharma ingredients — operating with the same merchant-wholesaler-plus-formulation-support model as Vivatis.
• Caldic: European specialty distributor serving life science, food, and personal care manufacturers with formulation and ingredient sourcing services similar to Vivatis.
• Actylis (formerly Aceto): Specialty manufacturer and distributor of pharmaceutical intermediates, APIs, and nutraceutical ingredients with GMP/regulatory capabilities — closely comparable to Vivatis's pharma-ingredient distribution core.
• PharmaZell / Caesar & Loretz-style API specialists: European API and intermediate specialists with GMP supply into generics and formulation customers — direct comparables for Vivatis's pharma division.
• Azelis: Specialty ingredients distributor with deep coverage in life sciences, nutrition, and personal care across Europe — comparable customer base and supplier-partner business model.

Broad incumbents

• Givaudan (Naturex/Activ'Inside-adjacent): Global flavor, fragrance, and natural ingredients major with significant activity in botanical extracts and nutraceutical actives — competes with and supplies Vivatis-type distributors.
• Univar Solutions: Large multinational chemicals and ingredients distributor with a pharma/nutraceutical vertical — competes in the same wholesale ingredient space but at a much broader portfolio level.
• dsm-firmenich: Mega-incumbent in nutrition, health, and flavors with a large portfolio of branded functional ingredients — both an ecosystem player and a competitor for Vivatis's proprietary positioning.
• Brenntag: World's largest chemical and ingredient distributor with life-sciences and nutrition divisions — a much larger incumbent operating in the pharmaceutical/nutraceutical supply chain that Vivatis addresses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vivatis-pharma-gmbh
• Instagraminstagram.com/vivatispharma

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivatis Pharma